[Control of arterial pressure in diabetic nephropathy]

MeSH terms

• Adrenergic beta-Antagonists / therapeutic use
• Adult
• Albuminuria / etiology
• Albuminuria / physiopathology
• Angiotensin-Converting Enzyme Inhibitors / administration & dosage
• Angiotensin-Converting Enzyme Inhibitors / pharmacology
• Angiotensin-Converting Enzyme Inhibitors / therapeutic use
• Antihypertensive Agents / administration & dosage
• Antihypertensive Agents / therapeutic use*
• Blood Pressure / drug effects
• Blood Pressure / physiology
• Cardiovascular Diseases / etiology
• Cardiovascular Diseases / prevention & control
• Child
• Clinical Trials as Topic
• Diabetes Mellitus, Type 1 / complications
• Diabetes Mellitus, Type 2 / complications*
• Diabetes Mellitus, Type 2 / prevention & control
• Diabetic Nephropathies / complications*
• Diabetic Nephropathies / physiopathology
• Diabetic Nephropathies / prevention & control
• Disease Progression
• Humans
• Hypertension / complications*
• Hypertension / drug therapy
• Hypertension, Renal / complications
• Hypertension, Renal / drug therapy
• Hypertension, Renal / physiopathology
• Insulin Resistance / physiology
• Kidney Function Tests
• Prediabetic State / drug therapy*
• Prediabetic State / physiopathology
• Renin-Angiotensin System / drug effects
• Renin-Angiotensin System / physiology*
• Risk Factors